Avadel Pharma (AVDL) Tops Q2 EPS by 14c, Beats on Revenues; Lowers FY17 Revenue Guidance Below Consensus
Go back to Avadel Pharma (AVDL) Tops Q2 EPS by 14c, Beats on Revenues; Lowers FY17 Revenue Guidance Below Consensus| (NASDAQ: AVDL) | Delayed: 21.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.64 | 52 Week High | $ | |||
| Open | $21.64 | 52 Week Low | $ | |||
| Day High | $21.64 | P/E | N/A | |||
| Day Low | $21.64 | EPS | $ | |||
| Volume | 2 | |||||

